In this study, we first reported the beneficial role of curcumin in the adult hippocampus neurogenesis through both Wnt/β-catenin and BDNF in Aβ1–42 mice by targeting PI3K/Akt, providing a new target and direction for drug therapy of AD. Here, AKT1 is linked to Alzheimer disease.